Medical devices, healthcare technology and the business of care
510(k) clearance · K252628

CASSIE

Wesper, Inc. · Decision date Apr 27, 2026

FDA DECISIONK252628

What did the FDA decide?

FDA records K252628 as a 510(k) premarket notification, with a decision dated Apr 27, 2026. The decision code SESE records a finding of substantial equivalence. This is a 510(k) clearance.

Regulatory pathway
510(k) premarket notification
Clinical specialty
Anesthesiology
Decision date
Apr 27, 2026

FDA source record

Regulatory record facts

Identifier
K252628
Regulatory pathway
510(k) premarket notification
Applicant
Wesper, Inc.
Product code
MNR
Decision code
SESE
Decision date
Apr 27, 2026
Source update
Nov 9, 2026
Original record
Open FDA source record

About this medical device

FDA device category: Ventilatory Effort Recorder.

Applicant
Wesper, Inc.
Product code
MNR
FDA device class
2

FDA decision timeline

  1. K252628 received

    Application receipt date recorded by FDA.

  2. K252628 · FDA decision

    SESE

Related devices and submissions

Explore the linked device profile

Other records with product code MNR

Product / regulatory recordCompanyPathwayDecision dateSource
CNSAC Medshop GmbH510(k) clearanceSep 24, 2026FDA
Itamar Medical , Ltd.510(k) clearanceJul 31, 2026FDA
Huneo, LLC510(k) clearanceJul 15, 2026FDA
RX-1 SleepK253148
Vivaquant, Inc. Dba Rhythm Express510(k) clearanceJun 22, 2026FDA

A shared product code identifies a classification relationship; it does not establish clinical equivalence.

Regulatory context

A 510(k) submission seeks a finding of substantial equivalence to a legally marketed device. A clearance and a PMA approval are different regulatory decisions.

Read our guide to FDA clearance and approval · FDA’s explanation of this pathway

Manufacturer intelligence

Wesper, Inc.

Headquarters
Not reported
Brand website
Not reported
FDA applicant address
Long Island City, NY

Sources and methodology

FDA fields and approval-order wording are presented as source information. MedtechLedger explanations are identified separately and describe the scope of the recorded decision. Indications from an original PMA are historical unless confirmed against subsequent labeling and supplements.

How we use FDA records